




Type-D personality and depressive symptoms predict anxiety 12 months post-
percutaneous coronary intervention
van Gestel, Y.R.; Pedersen, S.S.; van de Sande, M.J.; de Jaegere, P.T.; Serruys, P.W.;
Erdman, R.A.M.; van Domburg, R.T.
Published in:




Publisher's PDF, also known as Version of record
Link to publication in Tilburg University Research Portal
Citation for published version (APA):
van Gestel, Y. R., Pedersen, S. S., van de Sande, M. J., de Jaegere, P. T., Serruys, P. W., Erdman, R. A. M., &
van Domburg, R. T. (2007). Type-D personality and depressive symptoms predict anxiety 12 months post-
percutaneous coronary intervention. Journal of Affective Disorders, 103(1-3), 197-203.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. Jan. 2022
Journal of Affective Disorders xx (2007) xxx–xxx
+ MODEL
JAD-03565; No of Pages 7
www.elsevier.com/locate/jad
ARTICLE IN PRESSResearch report
Type-D personality and depressive symptoms predict anxiety
12 months post-percutaneous coronary intervention
Yvette R.B.M. van Gestel a, Susanne S. Pedersen a,b, Meike van de Sande a,
Peter P.T. de Jaegere a, Patrick W. Serruys a, Ruud A.M. Erdman a,c,
Ron T. van Domburg a,⁎
a Department of Cardiology, Thoraxcenter, Ba 559, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
b CoRPS — Center of Research on Psychology in Somatic Diseases, Tilburg University, The Netherlands
c Department of Medical Psychology and Psychotherapy, Erasmus Medical Center Rotterdam, The Netherlands
Received 11 December 2006; received in revised form 29 January 2007; accepted 29 January 2007Abstract
Background:We examined whether type-D personality exerts a stable effect on anxiety over time and the clinical relevance of type-
D personality as a predictor of anxiety 12 months post-percutaneous coronary intervention (PCI).
Methods: Consecutive patients (n=416) with stable or unstable angina pectoris treated with PCI completed the Type-D Scale
(DS14) at baseline and the Hospital Anxiety and Depression Scale (HADS) at baseline and 12 months.
Results: At baseline, 26% of the patients were anxious, with 67% of these patients still being anxious 12 months post-PCI
( pb0.001). There was no significant change in anxiety between baseline and 12 months ( p=0.96) nor was the interaction effect
type-D personality by time significant ( p=0.41). However, type-D patients experienced significantly higher levels of anxiety than
non-type-D patients ( pb0.001). Type-D personality (OR: 2.89; CI: 1.57–5.34), depressive symptoms (OR: 3.27; CI: 1.73–6.18)
and anxiety at baseline (OR: 8.38; CI: 4.65–15.12) were independent predictors of anxiety 12 months post-PCI, adjusting for
baseline demographic and clinical characteristics.
Limitations: A limitation of the study is the attrition rate of 105 patients who did not complete the HADS at 12 months. No
information was available on the use of psychotropic medication and participation in cardiac rehabilitation, which could serve as
confounders.
Conclusion: Type-D exerted a stable effect on anxiety over time and was an independent predictor of anxiety 12 months post-PCI
together with depressive symptoms and anxiety at baseline. The DS14 could be used as a screening tool in clinical practice to
identify high-risk patients post-PCI.
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There is a substantial body of evidence showing that
psychological factors play a role in the pathogenesis of
coronary artery disease (CAD), with depression havingd depressive symptoms predict anxiety 12 months post-percutaneous
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Fig. 1. Flowchart of patient selection.
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ARTICLE IN PRESSbeen studied most extensively (Januzzi et al., 2000; Lett
et al., 2004; Astin et al., 2005; Nicholson et al., 2005). In
patients with established CAD, depression has been
associated with an increased risk of morbidity and
mortality (Denollet, 2000; Januzzi et al., 2000; Carney
and Freedland, 2003; Lett et al., 2004) and future
cardiac events (Musselman et al., 1998). These findings
were confirmed in a recent meta-analysis, showing that
post-myocardial infarction (MI) depression is associated
with a 2-fold increased risk of adverse clinical outcome
(van Melle et al., 2004).
Anxiety is a frequent co-morbid disorder of depression
(Clark et al., 1998; Januzzi et al., 2000; Grace et al., 2004).
However, anxiety has received far less attention than
depression, although anxiety has been associated with
increased risk of mortality (Januzzi et al., 2000; Eaker
et al., 2005), recurrent ischemic and arrhythmic events
(Grace et al., 2004), impaired health-related quality of life
(HRQL) (Astin et al., 2005; Pedersen et al., 2006a) and
increased health care consumption (Strik et al., 2003;
Grace et al., 2004). Despite these findings, anxiety is
frequently underrecognized and undertreated in cardiacPlease cite this article as: van Gestel, Y.R.B.M. et al. Type-D personality an
coronary intervention. J. Affect. Disord. (2007), doi:10.1016/j.jad.2007.01patients (Grace et al., 2004; Haworth et al., 2005). In
addition, little is known about predictors of anxiety.
Studying anxiety is not only important due to its asso-
ciations with prognosis, HRQL and health care consump-
tion, but also because it is an important patient-centered
outcome (Krumholz et al., 2005). A recent report of the
National Heart, Lung, and Blood InstituteWorkingGroup
on Outcomes Research on Cardiovascular Disease advo-
cates the studying of patient-centered outcomes and their
determinants, in order to enhance the applicability of
research results in clinical practice (Krumholz et al.,
2005). Knowledge of predictors of anxiety would help
identify these high-risk patients and may also aid in the
designing of more successful intervention trials.
Personality is an important determinant of the emo-
tional and physical health of patients with CAD
(Denollet, 2000). The distressed (type-D) personality,
defined by high negative affectivity and social inhibition
(Denollet, 2000), is associated with a wide range of
emotional distress including anxiety, depressive symp-
toms, and post-traumatic stress disorder (Denollet et al.,
2000; Pedersen and Denollet, 2003; Pedersen et al.,d depressive symptoms predict anxiety 12 months post-percutaneous
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Table 1







Males (%) 75 75 0.95
Age, mean (SD) 62 (10) 63 (11) 0.37
Married/partner (%) 84 84 0.86
Indication for PCI
Unstable angina (%) 53 44 0.08
Clinical variables
Multi-vessel disease (%) 53 61 0.15
Previous MI a (%) 41 40 0.90
Previous PCI b (%) 23 26 0.65
Previous CABGc (%) 12 14 0.49
Recent cardiac event d 8 10 0.46
Hypertension (%) 49 48 0.96
Dyslipidemia (%) 79 75 0.46
Diabetes mellitus (%) 21 18 0.48
Current smoking (%) 11 13 0.63
Cardiac medication
Aspirin (%) 96 96 0.90
Statins (%) 72 76 0.39
ACE-inhibitors (%) 13 8 0.13
Beta-blockers (%) 20 23 0.63
Diuretics (%) 4 1 0.02 ⁎
a Previous MI=myocardial infarction prior to the index event.
b Previous PCI=percutaneous coronary intervention prior to the
index event.
c Previous CABG=coronary artery bypass surgery prior to the index
event.
d MI, PCI, and CABG between baseline and 12 months.
⁎ pb0.05.
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ARTICLE IN PRESS2004b). Type-D also predicts recurrent cardiac events
and poor prognosis, independent of biomedical risk
factors (Denollet et al., 1996, 2000; Pedersen et al.,
2004a; Denollet, 2005; Denollet et al., 2006; Pedersen
et al., 2006b). In addition, type-D personality has been
identified as an independent predictor of the onset of
depressive symptoms post-percutaneous coronary inter-
vention (PCI) in patients free of depressive symptoms
(Pedersen et al., 2006b). Hence, type-D personality may
also be a predictor of anxiety in patients post-PCI. To
date, only one study has investigated the association
between type-D personality and anxiety in a pure
sample of PCI patients, but this study looked at
predictors of chronic anxiety (Spindler et al., 2006).
The objectives of the present study were: (1) to
investigate whether type-D personality exerts a stable
effect on anxiety between baseline and 12 months post-
PCI; and (2) to examine if type-D personality is an
independent predictor of anxiety at 12 months, adjusting
for baseline demographic and clinical characteristics,
and anxiety and depressive symptoms at the time of the
index PCI.Please cite this article as: van Gestel, Y.R.B.M. et al. Type-D personality an
coronary intervention. J. Affect. Disord. (2007), doi:10.1016/j.jad.2007.012. Methods
2.1. Study design and participants
Between July 1, 2003 and July 1, 2004 a series of
consecutive patients with stable or unstable angina treated
with PCI at the ErasmusMedical Center Rotterdam, using
the paclitaxel-eluting stent (PES) as the default stent, were
included in the current study. Of the 845 patients, 116
were excluded due to language and 19 patients diedwithin
the first 4 weeks. Of the remaining 710 patients, 536 (75%
response rate) completed a set of standardized and
validated psychological questionnaires 4 weeks post-
PCI, which will be referred to as baseline in the remainder
of the paper. Differences on baseline characteristics
between responders and excluded/non-responders were
found on smoking status and dyslipidemia. Excluded and
non-responders were more likely to smoke (22% versus
14%; p=0.003) but less likely to suffer from dyslipidemia
(63% versus 74%; p=0.001). No other differences were
found on baseline characteristics, including cardiac
medication.
Only patients who had a score on the anxiety measure
(i.e. the Hospital Anxiety and Depression Scale) both at
the time of the index PCI and at 12 months qualified for
inclusion in the current study. See flowchart of the patient
selection (Fig. 1).
The study was approved by the local medical ethics
committee and conducted in accordance with the Helsinki
Declaration. All patients provided written informed
consent.
2.2. Measures
2.2.1. Demographic and clinical variables
Demographic variables included gender, age, and
marital status. Clinical variables included indication for
PCI (stable or unstable angina), multi-vessel disease,
previous myocardial infarction (MI), previous PCI,
previous coronary artery bypass graft surgery (CABG),
hypertension, dyslipidemia, diabetes mellitus, and
current smoking behavior. A recent cardiac event was
defined as MI, PCI or CABG between the index PCI and
12 months. Cardiac medication included aspirin, statins,
ACE-inhibitors, beta-blockers, and diuretics. All clini-
cal variables were obtained from the medical records at
4 weeks, referred to as baseline in the remainder of the
article.
2.2.2. Type-D personality
Type-D personality was assessed at baseline using
the 14-item Type-D Scale (DS14) (Denollet, 2005). Thed depressive symptoms predict anxiety 12 months post-percutaneous
.030
Table 2
Univariable and multivariable predictors of anxiety at 12 months
Univariable Multivariable
OR [95% CI] p OR [95% CI] p
Type-D personality 5.65 [3.49–9.15] 0.00‡ 2.89 [1.57–5.34] 0.001⁎
Depressive symptoms 6.51 [3.98–10.65] 0.00‡ 3.27 [1.73–6.18] 0.000‡
Anxiety (at baseline) 11.92 [7.17–19.83] 0.00‡ 8.38 [4.65–15.12] 0.000‡
Male gender 0.82 [0.51–1.33] 0.42 0.80 [0.41–1.58] 0.53
Age 0.98 [0.96–0.99] 0.01⁎ 0.99 [0.96–1.02] 0.42
Living alone 0.76 [0.41–1.39] 0.37 0.46 [0.20–1.04] 0.06
Multi-vessel disease 0.60 [0.39–0.92] 0.02⁎ 0.66 [0.37–1.20] 0.18
Unstable angina 1.23 [0.80–1.88] 0.34 0.98 [0.55–1.72] 0.93
Previous cardiac history a 0.94 [0.61–1.44] 0.77 0.85 [0.48–1.51] 0.58
Hypertension 0.74 [0.48–1.13] 0.16 0.88 [0.49–1.59] 0.67
Dyslipidemia 0.92 [0.56–1.50] 0.72 0.62 [0.32–1.19] 0.15
Diabetes mellitus 1.29 [0.76–2.18] 0.35 1.65 [0.81–3.36] 0.17
Current smoking 1.48 [0.79–2.75] 0.22 1.02 [0.41–2.52] 0.97
Recent cardiac event b 1.77 [0.90–3.46] 0.10 0.98 [0.55–1.72] 0.93
⁎pb0.05; ‡pb0.001.
a Previous MI, PCI or CABG.
b MI, PCI, CABG between baseline and 12 months.
Fig. 2. Anxiety score at baseline and 12 months post-PCI stratified by
type-D personality⁎.
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ARTICLE IN PRESSscale consists of two subscales, negative affectivity
(NA) and social inhibition (SI). Each subscale com-
prises seven items, which are answered on a 5-point
Likert scale from 0 to 4 with a score range of 0–28 per
subscale. The NA subscale covers dysphoria, anxiety,
and irritability (e.g. “I often feel unhappy” and “I often
find myself worrying about something”); the SI subscale
covers discomfort in social interactions, reticence, and
lack of social poise (e.g. “I make contact easily when I
meet people” and “When socializing, I don't find the
right things to talk about”) (Denollet, 2005). A
standardized cut-off ≥10 was used for both subscales
to classify patients as type-D (Denollet, 2005). The
DS14 has a high level of internal consistency with
Cronbach's alpha= .88/.86 and 3-month test–retest
reliability r=.72/.82 for the NA and SI subscales,
respectively (Denollet, 2005). It is important to
emphasize that type-D personality is more than negative
affect, due to the inclusion of the social inhibition
component within the construct (Pedersen et al., 2006a).
In addition, it is the co-occurrence of SI and NA and not
the single traits that incurs an increased risk of adverse
health outcomes, with SI having been shown to
moderate the effect of NA on prognosis, also adjusting
for mood states (Denollet et al., 2006).
2.2.3. Anxiety and depression
The Hospital Anxiety and Depression Scale (HADS)
was used to assess anxiety and depressive symptoms at
baseline and 12 months post-PCI (Zigmond and Snaith,
1983). The scale consists of two subscales, a 7-item
anxiety and 7-item depression scale. Both 7-item scalesPlease cite this article as: van Gestel, Y.R.B.M. et al. Type-D personality an
coronary intervention. J. Affect. Disord. (2007), doi:10.1016/j.jad.2007.01are answered on a 4-point Likert scale from 0 to 3 with a
score range of 0–21. A cut-off ≥8 was used to
categorize patients with anxiety and depressive symp-
toms. This cut-off has an optimal sensitivity and
specificity (Bjelland et al., 2002). The HADS is a
reliable questionnaire that performs well in screening for
the separate dimensions of anxiety and depression
(Bjelland et al., 2002).
2.3. Statistical analyses
For the statistical analyses, SPSS for Windows
version 11.5 was used. Discrete variables were com-
pared using the chi-square test (Fisher's exact test when
appropriate) and are presented as percentages. Contin-
uous variables were compared with the Student's t-testd depressive symptoms predict anxiety 12 months post-percutaneous
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ARTICLE IN PRESSand are presented as means±SD. Analysis of variance
(ANOVA) for repeated measures was used to examine
the effect of type-D on anxiety over time. Univariable
and multivariable logistic regression analyses were
performed to evaluate predictors of anxiety at 12months.
Prior to analyses, the continuous variables anxiety and
depressive symptoms were dichotomized, using a
standardized cut-off ≥8 to classify patients with the
respective symptomatologies (Bjelland et al., 2002). In
multivariable analyses, we entered type-D personality,
anxiety and depressive symptoms at baseline, gender,
age, marital status, multi-vessel disease, indication for
PCI, previous cardiac history, hypertension, dyslipide-
mia, diabetes, and current smoking simultaneously. In
order to examine whether the addition of type-D
personality to a multivariable model comprising demo-
graphic and clinical baseline characteristics, and anxiety
and depressive symptoms at baseline, added to the
prediction of anxiety at 12 months, we performed a
hierarchical logistic regression analysis. Given that
cardiac events occurring between the index PCI and
12 months may influence levels of anxiety, this variable
was also entered into the multivariable model. Results
are presented as odds ratio (OR) with 95% confidence
intervals (CI). All statistical tests were two-tailed, and




The mean age of the 416 included patients was
63 years (SD=11 years) and 75% were male. At
baseline, the prevalence of type-D personality was 25%.
Baseline characteristics stratified by type-D personality
are shown in Table 1. No significant differences on
baseline characteristics were found between type-D and
non-type-D patients, apart from type-Ds more likely
being prescribed diuretics (Table 1). At baseline, 26% of
the patients were anxious with 67% of these patients still
being anxious 12 months post-PCI ( pb0.001).
3.2. Change in anxiety over time by type-D personality
ANOVA for repeated measures showed that type-D
patients had a significantly higher score on anxiety than
non-type-D patients ( pb0.001) (Fig. 2). There was no
significant change in anxiety over time ( p=0.96) nor
was the interaction effect type-D personality by time
significant ( p=0.41), indicating that type-D exerted a
stable effect on anxiety over time.Please cite this article as: van Gestel, Y.R.B.M. et al. Type-D personality an
coronary intervention. J. Affect. Disord. (2007), doi:10.1016/j.jad.2007.013.3. Predictors of anxiety 12 months post-PCI
In unadjusted analysis, type-D personality (OR: 5.65;
CI: 3.49–9.15), depressive symptoms (OR: 6.51; CI:
3.98–10.65) and anxiety at baseline (OR: 11.92; CI:
7.17–19.83) were associated with anxiety at 12 months
(Table 2). A cardiac event between the index PCI and
12 months was not associated with anxiety at 12 months
( p=0.10). Hence, anxiety at 12 months could not be
accounted for by a cardiac event occurring during the
follow-up period.
Type-D personality (OR: 2.89; CI: 1.57–5.34),
depressive symptoms (OR: 3.27; CI: 1.73–6.18) and
anxiety at baseline (OR: 8.38; CI: 4.65–15.12) were
independent predictors of anxiety at 12 months, adjust-
ing for all other baseline characteristics.
These findings were confirmed with linear regression
analysis, using continuous scores of anxiety, with type-
D remaining an independent predictor of anxiety at
12 months adjusting for baseline characteristics, anxiety
and depressive symptoms at baseline (results not
shown).
The prediction of the model, comprising demograph-
ic and clinical baseline characteristics and anxiety and
depressive symptoms at the time of the index PCI,
improved significantly with the addition of type-D
personality (χ2 =11.243 (df=1), p=0.001).
4. Discussion
To our knowledge, only one study has examined the
impact of type-D personality on anxiety in a pure sample
of PCI patients (Spindler et al., 2006). We found no
change in anxiety between the index PCI and 12 months
nor was the interaction effect type-D personality by
anxiety significant, showing that type-D personality
exerted a stable effect on anxiety over time. Type-D
patients experienced significantly higher levels of
anxiety at both time points compared with non-type-D
patients. Type-D personality, anxiety and depressive
symptoms at baseline were independent predictors of
increased anxiety 12 months post-PCI, adjusting for
demographic and clinical risk factors.
The results of the current study showed that once
present, symptoms of anxiety tend not to remit over the
course of 12 months. Of note, the patients who were
anxious at baseline, 67% were still anxious 12 months
post-PCI. This is in accordance with the findings of
Spindler et al. (2006). Similarly, studies of MI patients
found that 26% of patients were anxious during hospital
admission, with 53% of these patients continuing to be
anxious 12 months post-MI (Lane et al., 2002). Ind depressive symptoms predict anxiety 12 months post-percutaneous
.030
6 Y.R.B.M. van Gestel et al. / Journal of Affective Disorders xx (2007) xxx–xxx
ARTICLE IN PRESSpatients with unstable angina or MI, Grace and
colleagues (2004) found a prevalence rate of 36%,
with 54% exhibiting persistent symptoms of anxiety at
12 months (Grace et al., 2004).
Type-D personality and depressive symptoms were
both independent predictors of anxiety at 12 months,
with a 3-fold associated risk. It is noteworthy that both
factors remained significant when adjusting for baseline
symptoms of anxiety. This emphasizes the importance
of studying anxiety and depression together, which has
also been advocated by others (Clark et al., 1998). It also
points to the independence of the constructs of type-D
personality and depressive symptoms, and that these
risk factors should be studied in their own right. Type-D
personality has in previous studies been shown to
predict prognosis in cardiac patients above and beyond
mood states, such as anxiety and depression (Denollet
et al., 2000, 2006). In addition, type-D has previously
been associated with symptoms of anxiety (Pedersen
and Denollet, 2006), but these studies were conducted in
a mixed group of CAD patients and prior to the
introduction of drug-eluting stents and not in a pure
sample of PCI patients.
The results of the present study have implications for
research and clinical practice. In clinical practice, it is
essential to identify PCI patients at high risk for anxiety
(i.e. those with a type-D personality or depressive
symptoms), given evidence that anxiety is a risk factor
for morbidity and mortality (Januzzi et al., 2000; Eaker
et al., 2005), impaired HRQL (Pedersen and Denollet,
2003; Astin et al., 2005), and increased health care
consumption (Strik et al., 2003; Grace et al., 2004). The
relative stability and persistence of anxiety symptoms
once manifest suggest that it may be important to screen
patients already 4 weeks post-PCI. Although either the
DS14 or the depression subscale of the HADS could be
used as screening tools in clinical practice, we would
suggest using the DS14 given that type-D is a stable
personality taxonomy with stable effects on behavior
and health outcomes, as also shown in the current study.
By contrast, anxiety and depression are considered state
measures and hence may fluctuate across time and
situations. In addition, type-D personality has been
associated with multiple health outcomes, including
distress, such as anxiety, depression, and post-traumatic
stress disorder, impaired quality of life, and increased
morbidity and mortality (Pedersen and Denollet, 2006).
Finally, the importance of participating in cardiac
rehabilitation should be emphasized to patients at high
risk for anxiety, as rehabilitation has been shown to
decrease both symptoms of anxiety and depression
(Januzzi et al., 2000). Additional treatment with e.g.Please cite this article as: van Gestel, Y.R.B.M. et al. Type-D personality an
coronary intervention. J. Affect. Disord. (2007), doi:10.1016/j.jad.2007.01cognitive–behavioral therapy and pharmacotherapy
may be warranted for subgroups of patients with
particularly elevated levels of anxiety (Januzzi et al.,
2000).
A limitation of our study is the attrition rate of 105
patients who did not complete the HADS at 12 months.
We also had no information on the use of psychotropic
medication and participation in cardiac rehabilitation,
which could serve as confounders. However, an advan-
tage of the current study was that anxiety was assessed at
two time points, and that we also adjusted for depressive
symptoms in addition to type-D personality and baseline
characteristics, given that anxiety and depression are
frequent co-morbid disorders.
In conclusion, symptoms of anxiety were stable over
a 12-month period showing that once manifest symp-
toms are not likely to remit. Type-D personality exerted
a stable effect on anxiety over time, and both type-D and
depressive symptoms were independent predictors of
anxiety 12 months post-PCI, with a 3-fold increased
risk, adjusting for baseline anxiety and demographic and
clinical risk factors. Screening for type-D personality
and depressive symptoms in clinical practice is
important in order to identify patients at risk of anxiety
12 months post-PCI. This subgroup of patients may
require some form of psychosocial intervention in order
to prevent the onset and persistence of symptoms of
anxiety, as anxiety is a risk factor for clinical events,
increased health care consumption, and impaired
HRQL.
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